Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Intervention to Reverse Gastric Precancer

NCT06590454 is registered in ClinicalTrials.gov with Katherine Garman as lead sponsor.

NCT NCT06590454
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06590454 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Intervention to Reverse Gastric Precancer
Lead sponsor
Katherine Garman
Phase
Phase 2
Overall status
Recruiting
Start date
December 15, 2025
Completion date
October 1, 2026
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric intestinal metaplasia, gastric precancer